ANIK planned sale of 16,864 common shares

ANIK received a notice of intended sale of 16,864 shares of its common stock to be sold on NASDAQ, with an aggregate market value of $355,255.47 as of 08/07/2026.

Accepted by SEC EDGAR 08/07/2026 - 05:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ANIK received a notice of intended sale of 16,864 shares of its common stock to be sold on NASDAQ, with an aggregate market value of $355,255.47 as of 08/07/2026. This is disclosed under a Form 144 filing for proposed sales of restricted or control securities.

The filing also lists recent activity in the same securities: an open market purchase by the issuer of 2,700 shares for cash on 03/05/2024, and restricted stock vesting of 14,164 shares on 06/20/2026 as compensation.

Key Figures

Shares proposed for sale: 16,864 shares Aggregate market value: $355,255.47 Issuer open market purchase: 2,700 shares +1 more

4 metrics

Shares proposed for sale 16,864 shares Common stock to be sold on NASDAQ under Form 144

Aggregate market value $355,255.47 Value of 16,864 common shares as of 08/07/2026

Issuer open market purchase 2,700 shares Common stock purchased for cash on 03/05/2024

Restricted stock vesting 14,164 shares Common stock vested as compensation on 06/20/2026

Key Terms

Form 144, Open Market Purchase, Restricted Stock Vesting

3 terms

Form 144 regulatory

"This is disclosed under a Form 144 filing for proposed sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Open Market Purchase financial

"an open market purchase by the issuer of 2,700 shares"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Restricted Stock Vesting financial

"restricted stock vesting of 14,164 shares on 06/20/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ANIK disclose?

The Form 144 for ANIK discloses a proposed sale of 16,864 common shares on NASDAQ with an aggregate market value of $355,255.47 as of 08/07/2026, along with certain recent transactions in the same security.

How many ANIK shares are planned to be sold under this Form 144?

The filing indicates a planned sale of 16,864 shares of ANIK common stock. These shares have an aggregate market value of $355,255.47 as of 08/07/2026, and are proposed to be sold on NASDAQ.

What recent stock transactions in ANIK are listed in the past 3 months section?

The disclosure lists an open market purchase by the issuer of 2,700 shares for cash on 03/05/2024, and restricted stock vesting of 14,164 shares on 06/20/2026 as compensation.

On which exchange are the ANIK Form 144 shares expected to be sold?

The proposed 16,864 shares of ANIK common stock are expected to be sold on NASDAQ. The filing ties these shares to an aggregate market value of $355,255.47 as of 08/07/2026.

What is the aggregate market value of ANIK shares covered by this Form 144?

The Form 144 states an aggregate market value of $355,255.47 for the 16,864 common shares proposed for sale, based on pricing as of 08/07/2026 and the planned sale on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001189883
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Anika Therapeutics, Inc.
SEC File Number	001-14027
Address of Issuer	32 WIGGINS AVENUE BEDFORD MASSACHUSETTS 01730
Phone	(781) 457-9000
Name of Person for Whose Account the Securities are To Be Sold	Jellison William R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16864	355255.47	13382966	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/05/2024	Open Market Purchase	Issuer			2700	03/05/2024	Cash
Common	06/20/2026	Restricted Stock Vesting	Issuer			14164	06/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Regarding today's sale, 2,700 shares were sold in the account of the William R Jellison Trust of which William R. Jellison is a trustee and an account stakeholder.
Date of Notice	08/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for William R. Jellison.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)